COVID Variant

Some of Vanderbilt University’s leading experts on vaccines, infectious disease and public health came together for a special panel discussion on March 10 to talk about the future of the COVID-19 pandemic. The virtual event, “The COVID Conundrum: What’s Next,” was hosted by the Chancellor’s Lecture Series in partnership with the Vanderbilt School of Medicine Basic Sciences. Read More

Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%. Read More

Graham Reside, executive director of the Cal Turner Program for Moral Leadership in the Professions and assistant professor at Vanderbilt Divinity School, discusses how the evolving pandemic has challenged views on illness as a moral issue. Read More

Dr. William Schaffner, an internationally renowned infectious disease specialist and public health expert, shares what you should know about the latest COVID-19 variant wave, including information about breakthrough symptoms for the vaccinated population. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what is known about the omicron variant and provides reminders on how to stay protected this season. Read More

A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. Read More

Researchers at Vanderbilt University Medical Center have found that people recovering from COVID-19 and those vaccinated against the causative virus, SARS-CoV-2, produce identical clones, or groups, of antibody-producing white blood cells. Read More

Five monoclonal antibody “cocktails,” including one developed at Vanderbilt University Medical Center (VUMC), are protective in animal studies against several variant strains of COVID-19, according to a report this week in the journal Nature. Read More